Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

By sjmartinez • August 2, 2024

Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats AJS, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR. Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2024 Aug 1. doi: 10.1002/ejhf.3340. Epub ahead of print. PMID: 39087551.

Tags: cardio‐oncology, Cardiology/Epi, cardiotoxicity, Hematology/Oncology, Immunotherapies, Publications

Association of RSV Vaccination With Clinical Outcomes in Older Adults With Heart Failure: A Propensity-Matched Analysis

Khan A, Shabbir MR, Nasrallah J, Imtiaz M, Thyagaturu H, Fudim M, Mentz RJ, Fonarow GC. Association of RSV Vaccination With Clinical Outcomes in Older[...]

Trends in Guideline Directed Medical Therapy Use in Heart Failure With a Mildly Reduced Ejection Fraction

Girard AA, Martinez OC, Ikeaba U, Jawad MA, Ikemura N, Chiswell K, Greene SJ, Fonarow GC, Chan PS, Sauer AJ, Spertus JA. Trends in Guideline[...]

Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026

Irannejad K, Mora R, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026. JACC[...]